Dianthus Therapeutics, Inc. · XETR:87E

Dianthus Therapeutics, Inc. shareholders

As of Sep 30, 2026, 267 institutions reported holding Dianthus Therapeutics, Inc. Largest: Fidelity, T. Rowe Price and Vanguard. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Dianthus Therapeutics, Inc.ChangeFiled
Fidelity8.55M+353KNov 10, 2026
T. Rowe Price8.09M+1.69MNov 16, 2026
Vanguard4.44M+1.35MNov 16, 2026
BlackRock4.39M+266KNov 13, 2026
Wellington3.01M−224KNov 16, 2026
Fairmount Funds Management LLC2.54Mno changeNov 16, 2026
State Street2.53M+177KNov 12, 2026
Avidity Partners Management LP1.9M−205KNov 16, 2026
Octagon Capital Advisors LP1.69M−155KNov 16, 2026
TCG Crossover Management, LLC1.68Mno changeNov 16, 2026

Dianthus Therapeutics, Inc. insider trades